Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Pear Therapeutics to Participate in a Virtual Panel Discussion at the SVB Leerink CybeRx Series: Digital Health ? Innovators & Disruptors


Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual panel discussion entitled "Emerging World of Digital Therapeutics" at the SVB Leerink CybeRx Series: Digital Health ? Innovators & Disruptors on Thursday, May 21 at 12:35 p.m. Eastern Time.

About Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas. Pear's lead product, reSET®, for the treatment of Substance Use Disorder, was the first PDT to receive marketing authorization from FDA to treat disease. Pear's second product, reSET-O®, for the treatment of Opioid Use Disorder, was the first PDT to receive Breakthrough Designation. Pear's third product, Somrysttm for the treatment of chronic insomnia, was the first PDT submitted through FDA's traditional 510(k) pathway while simultaneously reviewed through FDA's Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.


These press releases may also interest you

at 14:28
Nuventive, the data-informed improvement companytm, today announced a partnership with D2L, a global learning technology company, to simplify student outcomes analysis and advancement. By linking reports from the D2L Brightspace learning management...

at 14:26
IgniteTech, the AI Enterprise Software Company, today announced the launch of Jive Personas. This pioneering new feature utilizes the power of Generative AI to create role-specific knowledge based personas, delivering information in the form of...

at 14:25
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 14:20
Mishe (say "mish-e"), an innovator in direct healthcare, announces the launch of Downstate's Transparent Access Plan, making SUNY Downstate Health Sciences University the first hospital system in the US to offer transparent upfront pricing for its...

at 14:19
Sharp Imaging and Information Company of America (Sharp), a division of Sharp Electronics Corporation (SEC), today announced that industry veteran, Dino Pagliarello, has joined Sharp as the new Vice President of Product Management and Production...

at 14:15
The "Poland Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering. The Polish gift card market demonstrates robust growth trends, with an...



News published on and distributed by: